NCNANasdaqPharmaceutical PreparationsFiscal year ends December 31
NuCana plc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 19, 2026
$0.98−0.01 (-1.30%)
Close on Oct 19, 2026
Share price
−$4.0928 (−80.73%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- EPS, diluted
- 0.00 GBP
- Free cash flow
- -£7.47M
- Diluted shares
- 20.93B
Valuation needs the share price. It fills in once daily prices are connected and converted from GBP.
Twelve years at a glance
Fiscal years 2014 to 2025, GBP
Operating income
-£20.11M
EPS, diluted
0.00 GBP
Free cash flow
-£7.47M
Reported period